Skip to content
healthcare.dev

Wixela Inhub

NDC 0378-9320, fluticasone propionate and salmeterol, powder, from Mylan Pharmaceuticals Inc..

Product NDC
0378-9320
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
POWDER
Route
RESPIRATORY (INHALATION)
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208891
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0378-9320 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FLUTICASONE PROPIONATE100 ug/1
  • SALMETEROL XINAFOATE50 ug/1

Pharmacologic classes

Adrenergic beta2-Agonists [MoA]; Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; beta2-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
0378-9320-32003789320321 INHALER in 1 CARTON (0378-9320-32) / 60 POWDER in 1 INHALER

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3beef422-8a07-4a45-9ba6-414511e4b7e2
  • NADAC price for package 00378932032

    GET /v1/drugs/nadac/00378932032

Use it

Look up 0378-9320 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0378-9320 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0378-9320. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.